Impact of ceftazidime/avibactam versus best available therapy on mortality from infections caused by carbapenemase-producing Enterobacterales (CAVICOR study)

IRENE GRACIA AHUFINGERJULIAN CARLOS DE LA TORRE CISNEROSELENA PÉREZ NADALESCLARA NATERA KINDELÁNLUIS MARTINEZ MARTINEZ2026-01-292026-01-29202210.1093/jac/dkac0492-s2.0-85129779494https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/34932Infectious DiseasesMicrobiology (medical)PharmacologyPharmacology (medical)Impact of ceftazidime/avibactam versus best available therapy on mortality from infections caused by carbapenemase-producing Enterobacterales (CAVICOR study)research article